HIV-specific cytotoxic T lymphocytes traffic to lymph nodes and localize at sites of HIV replication and cell death

Journal of Clinical Investigation

Volumn 105, Issue 10, 2000, Pages 1407-1417

  Brodie, Scott J ^a   Patterson, Bruce K ^b   Lewinsohn, Deborah A ^a,c   Diem, Kurt ^a   Spach, David ^a   Greenberg, Phillip D ^a,c   Riddell, Stanley R ^a,c   Corey, Lawrence ^a,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE; CHEMOKINE RECEPTOR CCR5; GRANZYME B; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; TRANSACTIVATOR PROTEIN; VIRUS PROTEIN;

APOPTOSIS; ARTICLE; CELL DEATH; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; LYMPH NODE; LYMPHOCYTE MIGRATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRUS LOAD; VIRUS REPLICATION;

EID: 0034028070     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI8707     Document Type: Article

References (40)

1. Klein, M.R., et al. 1995. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J. Exp. Med. 181:1365-1372.
2. + lymphocytes. Science. 283:857 860.
3. Lisziewicz, J., et al. 1999. Control of HIV despite the discontinuation of antiretroviral therapy. N. Engl. J. Med. 340:1683-1684.
4. Koup, R.A., et al. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:4650-4655.
5. Borrow, P., Lewicki, H., Hahn, B.H., Shaw, G.M., and Oldstone, M.B. 1994. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68:6103-6110.
6. Patterson, B.K., et al. 1999. Monitoring HIV-1 treatment in immune-cell subsets with ultrasensitive fluorescence-in-situ hybridisation. Lancet. 353:211-212.
7. Brodie, S.J., et al. 1999. In vivo migration and function of transferred HIV-1-specific cytotoxic T cells. Nat. Med. 5:34-41.
8. Musey, L., et al. 1997. Cytotoxic T cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N. Engl. J. Med. 337:1267-1274.
9. Berrey, M. M., et al. 2000. Treatment of primary HIV-1 infection with triple combination antiretroviral therapy reduces rapid progression to AIDS. J. Infect. Dis. In press.
10. McMichael, A. 1998. T cell responses and viral escape. Cell. 93:673-676.
11. Rowland-Jones, S.L., et al. 1999. Broadly cross-reactive HIV-specific cytotoxic T-lymphocytes in highly-exposed persistently seronegative donors. Immunol. Lett. 66:9-14.
12. Walter, E.A., et al. 1995. Reconstitution of cellular immunity against CMV in recipients of allogeneic bone marrow by adoptive transfer of T-cell clones from the donor. N. Engl. J. Med. 333:1038-1044.
13. Kohn, D.B., et al. 1995. Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nat. Med. 1:1017-1023.
14. Merrouche, Y., et al. 1995. Clinical application of retroviral gene transfer in oncology: results of a French study wich tumor-infiltrating lymphocytes transduced with the gene of resistance to neomycin. J. Clin. Oncol. 13:410-418.
15. + cells purified from granulocyte colony-stimulating factor (G-CSF)-mobilized infant and cord blood. Exp. Hematol. 26:185-187.
16. Contassot, E., et al. 1998. Retrovirus-mediated transfer of the herpes simplex type I thymidme kinase gene in alloreactive T lymphocytes. Hum. Gene Ther. 9:73-80.
17. Tan, R., et al. 1999. Rapid death of adoptively transferred T cells in acquired immunodeficiency syndrome. Blood. 93:1506-1510.
18. Riddell, S.R., et al. 1996. T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nat. Med. 2:216-223.
19. Brodie, S.J., de la Rosa, C., Howe, G., Travis, W.D., and Diem, K. 1999. Pediatric AIDS-associated lymphocytic interstitial pneumonia and pulmonary arterio-occlusive disease: role of VCAM-1/VLA-4 adhesion pathway and human herpesviruses. Am. J. Pathol. 154:1453-1464.
20. Miller, A.D. 1992. Human gene therapy comes of age. Nature. 357:455-460.
21. Heid, C.A., Stevens, J., Livak, K.J., and William, P.M. 1996. Real time quantitative PCR. Genome Res. 6:986-994.
22. Patterson, B.K., et al. 1993. Detection of HIV-1 DNA and messenger RNA in individual cells by PCR-driven in situ hybridization and flow cytometry. Science. 260:976-979.
23. Brodie, S.J., et al. 1998 Epizootic hemorrhagic disease: analysis of tissues by amplification and in situ hybridization reveals widespread orbivirus infection at low copy numbers. J. Virol. 72:3863-3871.
24. Brodie, S.J., et al. 1998. The effects of pharmacological and lentivirus-induced immune suppression on orbivirus pathogenesis: assessment of virus burden in blood monocytes and tissues by reverse transcription-in situ PCR. J. Virol. 72:5599-5609
25. Furtado, M.R., Balachandran, R., Gupta, P., and Wolinsky, S.M. 1991. Analysis of alternatively spliced human immunodeficiency virus type-1 mRNA species, one of which encodes a novel tat-env fusion protein. Virology. 185:258-270.
26. Brodie, S.J., et al. 1995. Ovine lentivirus expression and disease: virus replication, but not entry, is restricted to macrophages of specific tissues. Am. J. Pathol. 146:1-13.
27. + T cells from HIV-infected persons. J. Immunol. 153:412-420.
28. Cyster, J.G. 1999. Chemokines and cell migration in secondary lymphoid organs. Science. 286:2098-2102.
29. Dunbar, C.E., et al. 1995. Retrovirally marked CD34-cnriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood. 85:3048-3057.
30. Roskrow, M.A., et al. 1998. Administration of neomycin resistance gene marked EBV specific cytotoxic T-lymphocytes to patients with relapsed EBV-positive Hodgkin disease. Hum. Gene Ther. 9:1237-1250.
31. Embretson, J., et al. 1993 Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature. 362:359-362.
32. Diamond, C., et al. 1998. Human herpes virus eight in prostate tissue on men with Kaposi's sarcoma. J. Virol. 72:6223-6227.
33. Furtado, M.R., et al. 1999. Persistence of HIV-1 transcription in peripheral blood mononuclear cells in patients receiving potent anti-retroviral therapy. N. Engl. J. Med. 340:1614-1622.
34. Heslop, H.E., et al. 1996. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nat. Med. 2:551-555.
35. Terai, C., Kornbluth, R.S., Pauza, C.D., Richman, D.D., and Carson, D.A. 1991. Apoptosis as a mechanism of cell death in cultured T lymphocytes acutely infected with HIV-1. J. Clin. Invest. 87:1710-1715.
36. Oyaizu, N., et al. 1993. Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals. Blood. 82:3392-3400.
37. Groux, H., Monte, D., Bourrex, J.M., Capron, A., and Ameisen, J.C. 1992. Activation-induced death by apoptosis in CD4 T cells from human immunodeficiency virus-infected asymptomatic individuals. J. Exp. Med. 175:331-340.
38. Kinkel, T.H., et al. 1995. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nat. Med. 2:129-134.
39. Zajac, A.J., et al. 1998. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188:2205-2213.
40. + cells. J. Virol. 74:1018-1022.